| 3-CYCLOHEXYL-D-ALANINE METHYL ESTER HYDROCHLORIDE |
3-环己基-D-丙氨酸甲酯盐酸盐 |
144644-00-8 |
| 1-TERT-BUTOXYCARBONYLAMINO-CYCLOHEXANECARBOXYLIC ACID |
1-叔丁氧羰酰胺环己羧酸 |
115951-16-1 |
| 3-((tert-Butoxycarbonyl)aMino)cyclopentanecarboxylic acid |
3-(叔丁氧基羰基)环戊烷羧酸 |
855863-93-3 |
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
| Fmoc-3-(4-pyridyl)-D-alanine |
Fmoc-3-(4-吡啶基)-D-丙氨酸 |
205528-30-9 |
| Danirixin |
GSK1325756 |
954126-98-8 |
| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| KU-0063794 |
KU-0063794 |
938440-64-3 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| 1-Boc-3-hydroxy-3-pyrrolidinedicarboxylic acid Methyl ester |
1-BOC-3-羟基-3-羧酸甲酯吡咯烷 |
942190-61-6 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-26-8 |
| FMOC-ASP(OTBU)-THR(PSIME,MEPRO)-OH |
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 |
920519-32-0 |
| PLX4032 |
维罗非尼 |
918504-65-1 |
| Canagliflozin heMihydrate |
卡格列净半水合物 |
928672-86-0 |
| Simeprevir |
司美匹韦 |
923604-59-5 |
| Nilotinib Hydrochloride Monohydrate |
盐酸尼罗替尼一水合物 |
923288-90-8 |
